CClinicalTrials.gg
CompletedNCT01151111Updated May 8, 2014

Relaxation Guided Imagery for Treatment of Parkinson's Disease

An Early Phase 1 interventional study of Relaxation guided imagery in Parkinson's Disease, sponsored by Rambam Health Care Campus. Completed at 1 site in Israel. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2014-05-08.

Sponsored by Rambam Health Care Campus · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
30 Years and older
Sex
All
01

Study summary

Parkinson's disease patients may have pronounced ON-OFF motor fluctuations. These motor fluctuations are currently treated with medication and surgery, which are limited by their efficacy and side effects. Our study aims to determine whether relaxation guided imagery can alleviate the OFF state of PD patients and therefore can be used as an adjunct to conventional medication.

Read the detailed description

Parkinson's disease patients with pronounced ON-OFF motor fluctuations without dementia will participate in this study aimed to examine a possible beneficial effect of relaxation guided imagery on motor fluctuations. The study will include a baseline period two sessions of relaxation and a follow-up period. The relaxation sessions will be conducted individually. In one session patients will hear relaxing music and in the second they will undergo relaxation guided imagery. After each relaxation session patients will receive a CD with either relaxing music or RGI to listen to at home. They will be asked to fill out a diary at baseline and after each session. Before and after each relaxation session patients will be examined according to the Unified Parkinson's Disease Rating Scale and the examination will be videotaped. All patients will continue to receive the usual care from their medical providers. The main measure is change in UPDRS and secondary measure is change in daily OFF time.

02

Conditions studied

  • Parkinson's Disease

Browse trials for

Keywords

  • Parkinson's disease
  • Relaxation
  • Visual imagery
  • Motor fluctuations
  • Treatment
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 20 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Rambam Health Care Campus is the lead sponsor of 456 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with idiopathic Parkinson's disease suffering from motor fluctuations
  • H\&Y >2

Exclusion criteria

Exclusion Criteria:

  • Dementia
  • hearing impairment
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
20 participants (actual)

Interventions

  • BehavioralRelaxation guided imagery

    An individualized relaxation guided imagery session will be conducted. After the session patients will be given a CD with the RGI and asked to listen to it at home.

06

What researchers measure

Primary outcomes

  1. Change from baseline of Unified Parkinson's Disease Rating Scale (UPDRS)

    * Unified Parkinson's Disease Rating Scale (UPDRS) score after RGI as compared to baseline * OFF time after RGI as compared to baseline

    Time frame: 30 minutes

Secondary outcomes

  1. Change from baseline to week 2 in Clinical Global Impression Scale (CGI)

    Patient will fill out a CGI

    Time frame: 2 weeks

  2. Change from baseline to week 2 in PDQ39

    PDQ39 questionaire will be filled out by the patient

    Time frame: 2 weeks

  3. Change from baseline to minutes 30 of Unified Parkinson's Disease Rating Scale (UPDRS) after relaxing music

    * Unified Parkinson's Disease Rating Scale (UPDRS) score after relaxing music as compared to baseline * OFF time after relaxing music as compared to baseline

    Time frame: 30 minutes

  4. Change from baseline to week 2 in the number of OFF hours

    The mean number of daily OFF hours over 3 days after visit.

    Time frame: 2 weeks

  5. Change from baseline to month 3 in PDQ39

    PDQ39 questionaire will be filled out by the patient

    Time frame: 3 months

  6. Change from baseline to month 3 in Clinical Global Impression Scale (CGI)

    Patient will fill out a CGI

    Time frame: 3 months

  7. Change from baseline to week 1 in the number of OFF hours

    The mean number of daily OFF hours over 3 days after visit

    Time frame: 1 week

07

Study locations

1 site
  • Ilana Schleainger
    Haifa, Israel
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01151111
Lead sponsor
Rambam Health Care Campus
Responsible party
Ilana Schlesinger (Director, Movement Disorders Institute, Rambam Health Care Campus) — Principal investigator
First posted
Jun 25, 2010
Start date
May 2010
Primary completion
May 2012
Completion
May 2014
Last update
May 8, 2014

Study contacts

Ilana Schlesinger, M.D.
principal investigator · Rambam Health Care Campus

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion